Rachel Tsunemoto Hislop is Head of Research at Two Bear Capital in San Diego. She previously worked at Acorda Therapeutics and earned her PhD from University of California San Diego.
At firms with a similar stage, sector and check size.






One email when Rachel's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckRachel Tsunemoto Hislop is Head of Research at Two Bear Capital in San Diego. She previously worked at Acorda Therapeutics and earned her PhD from University of California San Diego.
Rachel Tsunemoto Hislop invests through Two Bear Capital, which writes checks of $3M to $10M at seed, series a.
A warm intro from a founder Two Bear Capital backed works best.
Acorda Therapeutics; medical affairs team at Acorda Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.